Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies |
journalArticle |
2016 |
Postel-Vinay, S.; Aspeslagh, S.; Lanoy, E.; Robert, C.; Soria, J. C.; Marabelle, A. |
Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial |
journalArticle |
2016 |
Blanchard, P.; Faivre, L.; Lesaunier, F.; Salem, N.; Mesgouez-Nebout, N.; Deniau-Alexandre, E.; Rolland, F.; Ferrero, J. M.; Houede, N.; Mourey, L.; Theodore, C.; Krakowski, I.; Berdah, J. F.; Baciuchka, M.; Laguerre, B.; Davin, J. L.; Habibian, M.; Culine, S.; Laplanche, A.; Fizazi, K. |
How to Model Survival In Cost-Effectiveness Analysis? Differences Between Markov and Partitioned Survival Analysis Models |
journalArticle |
2015 |
Minacori, R.; Bonastre, J.; Lueza, B.; Marguet, S.; Levy, P. |
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) |
journalArticle |
2015 |
Gourgou-Bourgade, S.; Cameron, D.; Poortmans, P.; Asselain, B.; Azria, D.; Cardoso, F.; A'Hern, R.; Bliss, J.; Bogaerts, J.; Bonnefoi, H.; Brain, E.; Cardoso, M. J.; Chibaudel, B.; Coleman, R.; Cufer, T.; Dal Lago, L.; Dalenc, F.; De Azambuja, E.; Debled, M.; Delaloge, S.; Filleron, T.; Gligorov, J.; Gutowski, M.; Jacot, W.; Kirkove, C.; MacGrogan, G.; Michiels, S.; Negreiros, I.; Offersen, B. V.; Penault Llorca, F.; Pruneri, G.; Roche, H.; Russell, N. S.; Schmitt, F.; Servent, V.; Thürlimann, B.; Untch, M.; van der Hage, J. A.; van Tienhoven, G.; Wildiers, H.; Yarnold, J.; Bonnetain, F.; Mathoulin-Pélissier, S.; Bellera, C.; Dabakuyo-Yonli, T. S. |
[Prostate brachytherapy: New techniques, new indications] |
journalArticle |
2018 |
Blanchard, P.; Graff-Cailleaud, P.; Bossi, A. |
Proton versus photon radiation-induced cell death in head and neck cancer cells |
journalArticle |
2019 |
Wang, L.; Han, S.; Zhu, J.; Wang, X.; Li, Y.; Wang, Z.; Lin, E.; Wang, X.; Molkentine, D. P.; Blanchard, P.; Yang, Y.; Zhang, R.; Sahoo, N.; Gillin, M.; Zhu, X. R.; Zhang, X.; Myers, J. N.; Frank, S. J. |
Prevalence of burnout, depression and job satisfaction among French senior and resident radiation oncologists |
journalArticle |
2018 |
Lazarescu, I.; Dubray, B.; Joulakian, M. B.; Blanchard, P.; Chauvet, B.; Mahe, M. A.; Mornex, F.; Rocher, F.; Thureau, S. |
In the immuno-oncology era, is anti-PD-1 or anti-PD-L1 immunotherapy modifying the sensitivity to conventional cancer therapies? |
journalArticle |
2017 |
Aspeslagh, S.; Matias, M.; Palomar, V.; Dercle, L.; Lanoy, E.; Soria, J. C.; Postel-Vinay, S. |
Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients |
journalArticle |
2016 |
Deutsch, E.; Haie-Meder, C.; Bayar, M. A.; Mondini, M.; Laporte, M.; Mazeron, R.; Adam, J.; Varga, A.; Vassal, G.; Magne, N.; Chargari, C.; Lanoy, E.; Pautier, P.; Levy, A.; Soria, J. C. |
Investigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study) |
journalArticle |
2017 |
Fresneau, Brice; Hackshaw, A.; Hawkins, D. S.; Paulussen, M.; Anderson, J. R.; Judson, I.; Litière, S.; Dirksen, U.; Lewis, I.; van den Berg, H.; Gaspar, N.; Gelderblom, H.; Whelan, J.; Boddy, A. V.; Wheatley, K.; Pignon, J. P.; De Vathaire, F.; Le Deley, M. C.; Le Teuff, G. |
Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis |
journalArticle |
2016 |
Ma, X.; Le Teuff, G.; Lacas, B.; Tsao, M. S.; Graziano, S.; Pignon, J. P.; Douillard, J. Y.; Le Chevalier, T.; Seymour, L.; Filipits, M.; Pirker, R.; Janne, P. A.; Shepherd, F. A.; Brambilla, E.; Soria, J. C.; Hainaut, P.; Group, L. A. C. E. Bio Collaborative |
Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy |
journalArticle |
2018 |
Ou, D.; Garberis, I.; Adam, J.; Blanchard, P.; Nguyen, F.; Levy, A.; Casiraghi, O.; Gorphe, P.; Breuskin, I.; Janot, F.; Temam, S.; Scoazec, J. Y.; Deutsch, E.; Tao, Y. |
How individual participant data meta-analyses have influenced trial design, conduct, and analysis |
journalArticle |
2015 |
Tierney, J. F.; Pignon, J. P.; Gueffyier, F.; Clarke, M.; Askie, L.; Vale, C. L.; Burdett, S.; Cochrane, I. P. D. Meta-analysis Methods Group |
Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study |
journalArticle |
2017 |
Colomba, E.; Le Teuff, G.; Eisen, T.; Stewart, G. D.; Fife, K.; Larkin, J.; Biondo, A.; Pickering, L.; Srinivasan, A.; Boyle, H.; Derosa, L.; Sternberg, C. N.; Recine, F.; Ralph, C.; Saldana, C.; Barthélémy, P.; Bernhard, J. C.; Gurney, H.; Verhoest, G.; Vauleon, E.; Bigot, P.; Berger, J.; Pfister, C.; Gravis, G.; Rodier, J. M.; Culine, S.; Caty, A.; Rolland, F.; Priou, F.; Escudier, B.; Albiges, L. |
Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials |
journalArticle |
2016 |
Le Tourneau, C.; Kamal, M.; Tsimberidou, A. M.; Bedard, P.; Pierron, G.; Callens, C.; Rouleau, E.; Vincent-Salomon, A.; Servant, N.; Alt, M.; Rouzier, R.; Paoletti, X.; Delattre, O.; Bieche, I. |
Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead |
journalArticle |
2015 |
Minard-Colin, V.; Brugières, L.; Reiter, A.; Cairo, M. S.; Gross, T. G.; Woessmann, W.; Burkhardt, B.; Sandlund, J. T.; Williams, D.; Pillon, M.; Horibe, K.; Auperin, A.; Le Deley, M. C.; Zimmerman, M.; Perkins, S. L.; Raphael, M.; Lamant, L.; Klapper, W.; Mussolin, L.; Poirel, H. A.; Macintyre, E.; Damm-Welk, C.; Rosolen, A.; Patte, C. |
The Use of Indirect Comparisons in Medicines Evaluation for their Access To Reimbursement by the Has |
journalArticle |
2015 |
Guichard, M.; D'Andon, A.; Rumeau Pichon, C.; Borget, I. |
The association between coffee consumption and bladder cancer in the bladder cancer epidemiology and nutritional determinants (BLEND) international pooled study |
journalArticle |
2019 |
Yu, E. Y.; Wesselius, A.; van Osch, F.; Stern, M. C.; Jiang, X.; Kellen, E.; Lu, C. M.; Pohlabeln, H.; Steineck, G.; Marshall, J.; Allam, M. F.; La Vecchia, C.; Johnson, K. C.; Benhamou, S.; Zhang, Z. F.; Bosetti, C.; Taylor, J. A.; Zeegers, M. P. |
The 5000% case: a glimpse into the financial issue of lung cancer treatment |
journalArticle |
2016 |
Remon, J.; Bonastre, J.; Besse, B. |
Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial |
journalArticle |
2018 |
Tao, Y.; Auperin, A.; Sire, C.; Martin, L.; Khoury, C.; Maingon, P.; Bardet, E.; Kaminsky, M. C.; Lapeyre, M.; Chatellier, T.; Alfonsi, M.; Pointreau, Y.; Jadaud, E.; Géry, B.; Zawadi, A.; Tourani, J. M.; Laguerre, B.; Coutte, A.; Racadot, S.; Hasbini, A.; Malaurie, E.; Borel, C.; Meert, N.; Cornely, A.; Ollivier, N.; Casiraghi, O.; Sun, X. S.; Bourhis, J. |
Statistical evaluation of surrogate endpoints with examples from cancer clinical trials |
journalArticle |
2016 |
Buyse, M.; Molenberghs, G.; Paoletti, X.; Oba, K.; Alonso, A.; Van der Elst, W.; Burzykowski, T. |
Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study |
journalArticle |
2018 |
Gaspar, N.; Occean, B. V.; Pacquement, H.; Bompas, E.; Bouvier, C.; Brisse, H. J.; Castex, M. P.; Cheurfa, N.; Corradini, N.; Delaye, J.; Entz-Werle, N.; Gentet, J. C.; Italiano, A.; Lervat, C.; Marec-Berard, P.; Mascard, E.; Redini, F.; Saumet, L.; Schmitt, C.; Tabone, M. D.; Verite-Goulard, C.; Le Deley, M. C.; Piperno-Neumann, S.; Brugieres, L.; Sfce; Gsf, Geto; group, Unicancer sarcoma |
Designs of preoperative biomarkers trials in oncology: a systematic review of the literature |
journalArticle |
2015 |
Marous, M.; Bieche, I.; Paoletti, X.; Alt, M.; Razak, A. R.; Stathis, A.; Kamal, M.; Le Tourneau, C. |
A comparison between different prediction models for invasive breast cancer occurrence in the French E3N cohort |
journalArticle |
2015 |
Dartois, L.; Gauthier, E.; Heitzmann, J.; Baglietto, L.; Michiels, S.; Mesrine, S.; Boutron-Ruault, M. C.; Delaloge, S.; Ragusa, S.; Clavel-Chapelon, F.; Fagherazzi, G. |
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials |
journalArticle |
2018 |
Early Breast Cancer Trialists' Collaborative, Group |
Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort |
journalArticle |
2018 |
Blanchard, P.; Davis, J. W.; Frank, S. J.; Kim, J.; Pettaway, C. A.; Pugh, T. J.; Pisters, L. L.; Ward, J. F.; Choi, S.; Chapin, B. F.; Hoffman, K.; Navai, N.; Achim, M.; McGuire, S. E.; Matin, S. F.; Nguyen, Q.; Mahmood, U.; Graber, W. J.; Chen, H. C.; Wang, X.; Kuban, D. A. |
Prognostic value of the texture analysis parameters of the initial computed tomographic scan for response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer |
journalArticle |
2019 |
Vandendorpe, B.; Durot, C.; Lebellec, L.; Le Deley, M. C.; Sylla, D.; Bimbai, A. M.; Amroun, K.; Ramiandrisoa, F.; Cordoba, A.; Mirabel, X.; Hoeffel, C.; Pasquier, D.; Servagi-Vernat, S. |
[A new classification for meibomian gland diseases with in vivo confocal microscopy] |
journalArticle |
2016 |
Randon, M.; Liang, H.; Abbas, R.; Michee, S.; Denoyer, A.; Baudouin, C.; Labbe, A. |
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials |
journalArticle |
2017 |
Arnold, D.; Lueza, B.; Douillard, J. Y.; Peeters, M.; Lenz, H. J.; Venook, A.; Heinemann, V.; Van Cutsem, E.; Pignon, J. P.; Tabernero, J.; Cervantes, A.; Ciardiello, F. |
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group |
journalArticle |
2016 |
Denkert, C.; Wienert, S.; Poterie, A.; Loibl, S.; Budczies, J.; Badve, S.; Bago-Horvath, Z.; Bane, A.; Bedri, S.; Brock, J.; Chmielik, E.; Christgen, M.; Colpaert, C.; Demaria, S.; Van den Eynden, G.; Floris, G.; Fox, S. B.; Gao, D.; Ingold Heppner, B.; Kim, S. R.; Kos, Z.; Kreipe, H. H.; Lakhani, S. R.; Penault-Llorca, F.; Pruneri, G.; Radosevic-Robin, N.; Rimm, D. L.; Schnitt, S. J.; Sinn, B. V.; Sinn, P.; Sirtaine, N.; O'Toole, S. A.; Viale, G.; Van de Vijver, K.; de Wind, R.; von Minckwitz, G.; Klauschen, F.; Untch, M.; Fasching, P. A.; Reimer, T.; Willard-Gallo, K.; Michiels, S.; Loi, S.; Salgado, R. |
[uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management] |
journalArticle |
2015 |
Luporsi, E.; Bellocq, J. P.; Barrière, J.; Bonastre, J.; Chetritt, J.; Le Corroller, A. G.; de Cremoux, P.; Fina, F.; Gauchez, A. S.; Lamy, P. J.; Martin, P. M.; Mazouni, C.; Peyrat, J. P.; Romieu, G.; Verdoni, L.; Mazeau-Woynar, V.; Kassab-Chahmi, D. |
Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer |
journalArticle |
2018 |
Devarakonda, S.; Rotolo, F.; Tsao, M. S.; Lanc, I.; Brambilla, E.; Masood, A.; Olaussen, K. A.; Fulton, R.; Sakashita, S.; McLeer-Florin, A.; Ding, K.; Le Teuff, G.; Shepherd, F. A.; Pignon, J. P.; Graziano, S. L.; Kratzke, R.; Soria, J. C.; Seymour, L.; Govindan, R.; Michiels, S. |
Influence of tumor-associated macrophages and HLA class I expression according to HPV status in head and neck cancer patients receiving chemo/bioradiotherapy |
journalArticle |
2018 |
Ou, D.; Adam, J.; Garberis, I.; Blanchard, P.; Nguyen, F.; Levy, A.; Casiraghi, O.; Gorphe, P.; Breuskin, I.; Janot, F.; Temam, S.; Scoazec, J. Y.; Deutsch, E.; Tao, Y. |
Chemotherapy for Nasopharyngeal Carcinoma - Current Recommendation and Controversies |
journalArticle |
2015 |
Sze, H.; Blanchard, P.; Ng, W. T.; Pignon, J. P.; Lee, A. W. |
Lung Adenocarcinoma as Part of the Li-Fraumeni Syndrome Spectrum: Preliminary Data of the LIFSCREEN Randomized Clinical Trial |
journalArticle |
2017 |
Caron, O.; Frebourg, T.; Benusiglio, P. R.; Foulon, S.; Brugières, L. |
Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumab |
journalArticle |
2016 |
Lassau, N.; Coiffier, B.; Kind, M.; Vilgrain, V.; Lacroix, J.; Cuinet, M.; Taieb, S.; Aziza, R.; Sarran, A.; Labbe-Devilliers, C.; Gallix, B.; Lucidarme, O.; Ptak, Y.; Rocher, L.; Caquot, L. M.; Chagnon, S.; Marion, D.; Luciani, A.; Feutray, S.; Uzan-Augui, J.; Benatsou, B.; Bonastre, J.; Koscielny, S. |
Mutation-Independent Activation of the Anaplastic Lymphoma Kinase in Neuroblastoma |
journalArticle |
2016 |
Regairaz, M.; Munier, F.; Sartelet, H.; Castaing, M.; Marty, V.; Renauleaud, C.; Doux, C.; Delbe, J.; Courty, J.; Fabre, M.; Ohta, S.; Vielh, P.; Michiels, S.; Valteau-Couanet, D.; Vassal, G. |
Impact of experience in breast cancer surgery on survival: the role of quality of care in a registry-based cohort. |
journalArticle |
2018 |
Taban F, Elia N, Rapiti E, Rageth C, Fioretta G, Benhamou S, Than Lam G, David-Montefiore E, Bouchardy C |
Postoperative radiotherapy for non-small cell lung cancer |
journalArticle |
2016 |
Burdett, S.; Rydzewska, L.; Tierney, J.; Fisher, D.; Parmar, M. K.; Arriagada, R.; Pignon, J. P.; Le Pechoux, C.; Group, Port Meta-analysis Trialists |
Long-term evaluation of urinary, sexual, and quality of life outcomes after brachytherapy for penile carcinoma |
journalArticle |
2018 |
Gambachidze, D.; Lebacle, C.; Maroun, P.; Escande, A.; Bossi, A.; Blanchard, P.; Deutsch, E.; Haie-Meder, C.; Chargari, C. |